The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma
Open accessAbstract
AIM: To assess the clinical features and prognosis of 151 patients with extrahepatic metastases from primary hepatocellular carcinoma (HCC), and describe the treatment strategy for such patients. METHODS: After the diagnosis of HCC, all 995 consecutive HCC patients were followed up at regular intervals and 151 (15.2%) patients were found to have extrahepatic metastases at the initial diagnosis of primary HCC or developed such tumors during the follow-up period. We assessed their clinical features, prognosis, and treatment strategies. RESULTS: The most frequent site of extrahepatic metastases was the lungs (47%), followed by lymph nodes (45%), bones (37%), and adrenal glands (12%). The cumulative survival rates after the initial diagnosis of extrahepatic metastases at 6, 12, 24, and 36 mo were 44.1%, 21.7%, 14.2%, 7.1%, respectively. The median survival time was 4.9 mo (range, 0-37 mo). Fourteen patients (11%) died of extrahepatic HCC, others died of primary HCC or liver failure. CONCLUSION: The prognosis of HCC patients with extrahepatic metastases is poor. With regard to the cause of death, many patients would die of intrahepatic HCC and few of extrahepatic metastases. Although most of HCC patients with extrahepatic metastases should undergo treatment for the primary HCC mainly, treatment of extrahepatic metastases in selected HCC patients who have good hepatic reserve, intrahepatic tumor stage (T0-T2), and are free of portal venous invasion may improve survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxicity and response criteria of the Eastern Cooperative Oncology Group
Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T., & Carbone, P. P. (1982) · AMERICAN JOURNAL OF CLINICAL ONCOLOGY · doi:10.1097/00000421-198212000-00014 · Cited by 11,647
Extrahepatic Metastases of Hepatocellular Carcinoma
Katyal, S., Oliver, J. H., Peterson, M. S., Ferris, J. V., Carr, B. S., & Baron, R. L. (2000) · Radiology · doi:10.1148/radiology.216.3.r00se24698 · Cited by 742
Clinical features of hepatocellular carcinoma with extrahepatic metastases
NATSUIZAKA, M., OMURA, T., AKAIKE, T., KUWATA, Y., YAMAZAKI, K., SATO, T., KARINO, Y., TOYOTA, J., SUGA, T., & ASAKA, M. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03919.x · Cited by 527
Lam, C.-M., Lo, C., Yuen, W.-K., et al. (1998) · British journal of surgery · doi:10.1046/j.1365-2168.1998.00846.x · Cited by 130
Zeng, Z., Tang, Z., Fan, J., Qin, L., Ye, S.-L., Zhou, J., Sun, H., Wang, B., & Wang, J. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.058 · Cited by 101
Prognosis of hepatocellular carcinoma patients with extrahepatic metastases.
Okusaka, T., Okada, S., Ishii, H., et al. (1997) · PubMed · Cited by 98
Management of Adrenal Metastasis from Hepatocellular Carcinoma
Momoi, H., Shimahara, Y., Terajima, H., et al. (2002) · Surgery Today · doi:10.1007/s005950200210 · Cited by 77
Radiation Therapy for Adrenal Gland Metastases from Hepatocellular Carcinoma
Zeng, Z. (2005) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi020 · Cited by 65
Ishii, H. (2004) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyh135 · Cited by 33
Cited by
Fang, T., Lv, H., Lv, G., Li, T., Wang, C., Han, Q., Yu, L., Su, B., Guo, L., Huang, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02583-0 · Cited by 995
The diagnosis and treatment of hepatocellular carcinoma
Hartke, J., Johnson, M., & Ghabril, M. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2016.12.011 · Cited by 670
Hepatocellular carcinoma with extrahepatic metastasis: Clinical features and prognostic factors
Uchino, K., Tateishi, R., Shiina, S., Kanda, M., Masuzaki, R., Kondo, Y., Goto, T., Omata, M., Yoshida, H., & Koike, K. (2011) · Cancer · doi:10.1002/cncr.25960 · Cited by 427
Fang, Y., Xue, J.-L., Shen, Q., Chen, J., & Tian, L. (2012) · Hepatology · doi:10.1002/hep.25576 · Cited by 425
Recurrently deregulated lncRNAs in hepatocellular carcinoma
Yang, Y., Chen, L., Gu, J., Zhang, H., Yuan, J., Lian, Q., Lv, G., Wang, S., Wu, Y., Yang, Y.-C. T., et al. (2017) · Nature Communications · doi:10.1038/ncomms14421 · Cited by 337
Metadata
- Authors
- Uka, K.
- Venue
- World Journal of Gastroenterology
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2007
- Volume
- 13
- Issue
- 3
- Pages
- 414
- ISSN
- 1007-9327 (ISSN-L)
- OpenAlex
- W2102240822
- Cited by
- 477
- References
- 9
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. https://app.cochat.ai/papers/10.3748/wjg.v13.i3.414
- The paper
- Uka, K. (2007). Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.v13.i3.414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.